首页> 外文期刊>Breast Cancer Research >Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays
【24h】

Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays

机译:使用染色质免疫沉淀和全基因组启动子微阵列分析两个表型不同的乳腺癌细胞亚群中Sox2的基因启动子占有率

获取原文
           

摘要

IntroductionAberrant expression of the embryonic stem cell marker Sox2 has been reported in breast cancer (BC). We previously identified two phenotypically distinct BC cell subsets separated based on their differential response to a Sox2 transcription activity reporter, namely the reporter-unresponsive (RU) and the more tumorigenic reporter-responsive (RR) cells. We hypothesized that Sox2, as a transcription factor, contributes to their phenotypic differences by mediating differential gene expression in these two cell subsets.MethodsWe used chromatin immunoprecipitation and a human genome-wide promoter microarray (ChIP-chip) to determine the promoter occupancies of Sox2 in the MCF7 RU and RR breast cancer cell populations. We validated our findings with conventional chromatin immunoprecipitation, quantitative reverse transcription polymerase chain reaction (qPCR), and western blotting using cell lines, and also performed qPCR using patient RU and RR samples.ResultsWe found a largely mutually exclusive profile of gene promoters bound by Sox2 between RU and RR cells derived from MCF7 (1830 and 456 genes, respectively, with only 62 overlapping genes). Sox2 was bound to stem cell- and cancer-associated genes in RR cells. Using quantitative RT-PCR, we confirmed that 15 such genes, including PROM1 (CD133), BMI1, GPR49 (LGR5), and MUC15, were expressed significantly higher in RR cells. Using siRNA knockdown or enforced expression of Sox2, we found that Sox2 directly contributes to the higher expression of these genes in RR cells. Mucin-15, a novel Sox2 downstream target in BC, contributes to the mammosphere formation of BC cells. Parallel findings were observed in the RU and RR cells derived from patient samples.ConclusionsIn conclusion, our data supports the model that the Sox2 induces differential gene expression in the two distinct cell subsets in BC, and contributes to their phenotypic differences.Electronic supplementary materialThe online version of this article (doi:10.1186/s13058-014-0470-2) contains supplementary material, which is available to authorized users.
机译:简介乳腺癌(BC)中已经报道了胚胎干细胞标记Sox2的异常表达。我们先前确定了两个表型不同的BC细胞子集,这些子集是基于它们对Sox2转录活性报告基因的差异反应而分离的,即报告基因无反应(RU)和更具致瘤性的报告基因反应(RR)细胞。我们假设Sox2作为转录因子,通过介导这两个细胞亚群中的差异基因表达来促进它们的表型差异。方法我们使用染色质免疫沉淀和人类全基因组启动子微阵列(ChIP-chip)来确定Sox2的启动子占有率。在MCF7 RU和RR乳腺癌细胞群中。我们通过常规染色质免疫沉淀,定量逆转录聚合酶链反应(qPCR)和使用细胞系的Western blot验证了我们的发现,并使用患者RU和RR样品进行了qPCR。结果我们发现与Sox2结合的基因启动子在很大程度上是互斥的。来源于MCF7的RU细胞和RR细胞之间的差异(分别为1830和456个基因,只有62个重叠基因)。 Sox2与RR细胞中与干细胞和癌症相关的基因结合。使用定量RT-PCR,我们证实了15种这样的基因,包括PROM1(CD133),BMI1,GPR49(LGR5)和MUC15,在RR细胞中表达明显更高。使用siRNA敲低或Sox2的强制表达,我们发现Sox2直接有助于这些基因在RR细胞中的更高表达。 Mucin-15是BC中新型的Sox2下游靶标,有助于BC细胞的乳球形成。结论:总之,我们的数据支持该模型,即Sox2诱导BC中两个不同细胞亚群中差异基因表达,并促进它们的表型差异。本文的版本(doi:10.1186 / s13058-014-0470-2)包含补充材料,可供授权用户使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号